Guyana Shield Meeting on the Implementation of the Framework for Artemisinin Resistance Prevention, Containment, and Elimination in South America

Transcription

1 Guyana Shield Meeting on the Implementation of the Framework for Artemisinin Resistance Prevention, Containment, and Elimination in South America Paramaribo, Suriname July 2016 Background Artemisinin-based combination therapies (ACTs) are the recommended treatments for Plasmodium falciparum malaria in all malaria endemic areas of South America. Resistance of P. falciparum to the artemisinin drugs has already been detected in the Greater Mekong subregion of Southeast Asia and would represent a major setback to malaria control efforts if it were to develop in or spread to South America. Although artemisinin resistance has not been confirmed in the Americas, the interior of Guyana, Suriname, and French Guiana and bordering areas of Brazil and Venezuela (together known as the Guiana Shield) share many characteristics with the Greater Mekong subregion that increase the risk for selection of resistant parasites. These characteristics include higher levels of transmission of P. falciparum than in the rest of the Amazon Basin, highly mobile populations, ready availability and widespread use of a variety of antimalarial drugs of questionable quality, including artemisinin monotherapies, and lack of access to and use of formal malaria diagnostic and treatment facilities. The Framework for Artemisinin Resistance Prevention, Containment, and Elimination in South America was consolidated in November 2014 to prevent the development of artemisinin resistance in South America, and to contain and eliminate resistance if it should be confirmed. A longer-term objective of the framework is to eliminate P. falciparum malaria, as this will be the only sure way to avoid the selection of resistant parasites. While some activities geared towards responding to the recommendations in the framework were implemented through the work of the Amazon Malaria Initiative/Amazon Network for the Surveillance of Antimalarial Drug Resistance (AMI/RAVREDA) since 2014, targeted and intensified efforts are deemed essential especially in the light of the goals of the Global Technical Strategy (GTS) for Malaria , the commitments outlined in the Plan of Action for Malaria Elimination in the Americas , and the targets expressed by countries in their respective national malaria plans. s This meeting is a concrete step in intensifying efforts in the Guyana Shield towards the implementation of the Framework for Artemisinin Resistance Prevention, Containment, and Elimination in South America. Specifically, the meeting seeks to: Review the malaria strategies of Guyana Shield countries, the Framework for Artemisinin Resistance Prevention, Containment, and Elimination in South America and corresponding malaria elimination targets (as in the GTS ). Discuss challenges and gaps experienced by countries in the Guyana Shield in the delivery of the WHO recommended strategies. Review key interventions, relevant to the Guyana Shield, in scaling up malaria programmes towards Universal Access. Provide an overview of elimination procedures and the available resources, tools and opportunities for scaling up malaria programmes towards elimination. Facilitate joint planning of activities towards the implementation of the Framework for Artemisinin Resistance Prevention, Containment, and Elimination in South America and in support of malaria strategic plans of participating countries. 1

2 Expected results Linkages/discrepancies between country and regional strategies and regional policies, frameworks and targets and priority activities for the sub-region identified. Challenges and gaps in the implementation of the WHO recommended strategies identified. The susceptibility of the Guyana Shield countries to artemisinin-based combination therapies resistance discussed. Key interventions in reaching migrant/mobile populations in the Guyana Shield reviewed. The way forward on the proposed self-diagnosis and treatment intervention discussed and agreed on. Elimination procedures, available resources, tools and opportunities to scale up malaria programmes reviewed and discussed. Joint planning opportunities, a coordination and networking structure between countries created. Country plans with identified priorities including joint and aligned activities between countries developed. Day : Registration / Walk-in Opening session/ceremony :40 National anthem of Suriname National anthem of / Suriname Welcome Master of ceremonies Ms. J. Malmberg 8: Remarks PAHO/WHO Suriname PWR Suriname Dr. Y. Gebre :00 Opening Address Ministry of Health, Suriname Minister of Health HE. Ir. P. Pengel 2

3 Thematic area 1: Current malaria strategic policies, frameworks, plans and targets Review the malaria strategies of Guyana Shield countries, the Framework for Artemisinin Resistance Prevention, Containment, and Elimination in South America and corresponding malaria elimination targets (as in the GTS ). Expected result Linkages/discrepancies between country and regional strategies and regional policies, frameworks and targets and priority activities for the sub-region identified. Session 1: Regional policies, frameworks and target Moderator: Ms. Juanita Malmberg, PAHO-SUR Overview of global and regional malaria targets, policies and frameworks and discussion: Proposed activities in the Framework for Artemisinin Resistance Prevention, Containment, and Elimination in South America Dr. Rainier P. Escalada, PAHO / WHO Dr. Trent Ruebush, PAHO / WHO Session 2: Epidemiology and strategic plans of Guyana Shield countries Moderator: Dr. Angel Alvarez, PAHO-VEN and discussion: National malaria situation, targets, and strategic plan (Brazil) Dr. Paola Marchesini, PNCM/DEVEP/SVS/MS - Brazil and discussion: National malaria situation, targets, and strategic plan (French Guiana) Dr. Anne-Marie McKenzie, Regional Health Agency (ARS) - French Guiana : Coffee break National malaria situation, targets, and strategic plan (Guyana) National malaria situation, targets, and strategic plan (Suriname) National malaria situation, targets, and strategic plan (Venezuela) Dr. Sherry Vannooten, VCS / MOH-Guyana Dr. Ir. Helene Hiwat, Malaria Programme / MOH-Suriname Dr. Jesus Toro, MOH-Venezuela Lunch Open agenda for networking 3

4 Thematic area 2: Challenges and gaps in the implementation of WHO recommended strategies Discuss challenges and gaps experienced by countries in the Guyana Shield in the delivery of the WHO recommended strategies. Expected results Challenges and gaps in the implementation of the WHO recommended strategies identified. The susceptibility of the Guyana Shield countries to artemisinin-based combination therapies resistance discussed. Session 3: Challenges of countries in the implementation of WHO recommended strategies Moderator: Dr. Jean Seme Fils Alexandre, PAHO-GUY Challenges and gaps on program coordination Dr. Sherry Vannooten and management (including capacity building, / Mr. David Williams, monitoring staff performance, and malaria VCS / MOH-Guyana supply chain management): Perspectives from Guyana Challenges and gaps on vector control (including insecticide resistance surveillance): Perspectives from Brazil Challenges and gaps on surveillance and use of data for decision-making: Perspectives from Suriname Challenges and gaps engagement of various sectors in malaria prevention and elimination efforts: Perspectives from French Guiana Dr. Paola Marchesini, PNCM/DEVEP/SVS/MS - Brazil Dr. Ir. Helene Hiwat, Malaria Programme / MOH-Suriname Dr. Anne-Marie McKenzie, Regional Health Agency (ARS) - French Guiana : Coffee break Session 4: Current perspective Comparison of the Guyana Shield to the Greater Mekong sub-region Moderator: Dr. Lise Musset, Institute Pasteur - Cayenne Challenges and gaps on malaria case detection and treatment and anti-malarial drug resistance surveillance Dr. Mateusz Plucinski / Dr. Venkatachalam Udhayakumar, CDC Perspectives and experiences in the Greater Mekong sub-region: from Containment of Artemisinin Resistance to Malaria Elimination Dr. Stefan Hoyer, WHO-GMP End of day 1 4

5 Day Walk in Thematic area 3: Proposed interventions to scale up malaria programmes towards Universal Access Review key interventions, relevant to the Guyana Shield, in scaling up malaria programmes towards Universal Access. Expected results Key interventions in reaching migrant/mobile populations in the Guyana Shield reviewed. The way forward on the proposed self-diagnosis and treatment intervention discussed and agreed on. Session 5: Proposed interventions to scale up Universal Access to health services. Moderator: Dr. Trent Ruebush, PAHO/WHO Concept Note Review: Proposed use of malaria self-diagnosis and treatment kits by miners on the Fr. Guiana and Suriname border Ms. Laure Garancher, PAHO / ECC Integrated Approach to Malaria Efforts among Mobile Populations Mr. Hedley Cairo, Malaria Programme / MOH-SUR 60 min Thematic area 4: Requirements and available resources for scaling up malaria programmes towards elimination Provide an overview of elimination procedures and the available resources, tools and opportunities for scaling up malaria programmes towards elimination. Expected result Elimination procedures, available resources, tools and opportunities to scale up malaria programmes reviewed and discussed. Session 6: Elimination requirements and available tools Moderator: Ms. Rebecca Minneman, USAID Malaria Elimination and the WHO Certification Process (including subnational verification) Dr. Rainier P. Escalada, PAHO / WHO : Coffee break 5

6 WHO capacity building efforts towards malaria elimination Dr. Stefan Hoyer, WHO-GMP PAHO / AMRO tools and resources in support of country-level and subnational malaria elimination efforts (Hispaniola workshops and data validation / elimination capacity assessments in EMMIE countries). Dr. Monique Perret- Gentil, PAHO/WHO Lunch Open agenda for networking Resource Mobilization: Perspectives from USAID, Global Fund, and IDB, Moderator: Dr. Trent Ruebush, PAHO/WHO Panel Discussion 30 min Thematic area 5: Regional networking efforts and joint planning Facilitate joint planning of activities towards the implementation of the Framework for Artemisinin Resistance Prevention, Containment, and Elimination in South America and in support of malaria strategic plans of participating countries. Expected results Joint planning opportunities, a coordination and networking structure between countries created. Country plans with identified priorities including joint and aligned activities between countries developed. Session 7: Joint Planning Moderator: Dr. Monique Perret-Gentil, PAHO/WHO Proposed planning process, overview of prepared planning matrix Dr. Rainier P. Escalada, PAHO / WHO : Coffee break Brainstorm on sub-regional activities/priorities, 30 min opportunities for coordination networking, joint collaboration between countries and regional efforts Joint planning of countries Group work 60 min End of day 2 6

7 Day Walk in Session 7: Joint Planning cont d Moderator: Dr. Monique Perret-Gentil, PAHO/WHO Joint planning of countries Group work 2 hrs Coffee break Joint planning of countries Group work 1 hrs Lunch Plenary presentation country plan TBD: Brazil Open forum Plenary presentation country plan TBD: French Guiana Open forum Plenary presentation country plan TBD: Guyana Open forum Plenary presentation country plan TBD: Suriname Open forum Plenary presentation country plan TBD: Venezuela Open forum Closing Closing Master of Ceremonies Ms. J. Malmberg Remarks PAHO/WHO, Suriname PAHO/WHO Dr. Y. Gebre representative Closing Address Ministry of Health, Suriname Minister HE. Ir. P. Pengel End of the meeting 7